The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs
Open accessAbstract
Pancreatic cancer continues to be one of the world's most lethal cancers. Chemotherapy resistance in patients with advanced pancreatic cancer often accompany with dismal prognosis, highlighting the need to investigate mechanisms of drug resistance and develop therapies to overcome chemoresistance. This research was filed with the Chinese Clinical Trial Registry (ChiCTR2200061320). In order to isolate primary normal fibroblasts (NFs) and cancer-associated fibroblasts (CAFs) samples of pancreatic ductal adenocarcinoma (PDAC) and paracancerous pancreatic tissue from individuals diagnosed with PDAC were obtained. The exosomes were obtained using ultracentrifugation, and their characteristics were determined by Western blotting, nanoparticle tracking analysis, and transmission electron microscopy. CAF-derived miRNAs were analyzed by RT-qPCR and high-throughput sequencing. Gemcitabine (GEM) was employed to promote ferroptosis, and ferroptosis levels were determined by monitoring lipid reactive oxygen species (ROS), cell survival, and intracellular Fe2+ concentrations. To assess in vivo tumor response to GEM therapy, a xenograft tumor mouse model was utilized. Exosomes derived from CAFs in PDAC did not exhibit innate GEM resistance. CAFs promoted chemoresistance in PDAC cells following GEM treatment by secreting exosomes, and maintaining signaling communication with cancer cells. Mechanistically, miR-3173–5p derived from CAF exosomes sponged ACSL4 and inhibited ferroptosis after uptake by cancer cells. This work demonstrates a novel mode of acquired chemoresistance in PDAC and identifies the miR-3173–5p/ACSL4 pathway as a promising treatment target for GEM-resistant pancreatic cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Dou, D., Ren, X., Han, M., Xu, X., Ge, X., Gu, Y., & Wang, X. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02026 · Cited by 175
Self-citationRetractedHan, S., Liu, Q., Yang, Z., Ma, J., Liu, D., Yan, C., & Liang, D. (2022) · Disease Markers · doi:10.1155/2022/6400227 · Cited by 10
RetractedSung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21708 · Cited by 17,196
Ferroptosis: mechanisms, biology and role in disease
Jiang, X., Stockwell, B. R., & Conrad, M. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00324-8 · Cited by 7,505
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Von Hoff, D. D., Ervin, T., Arena, F. P., Chiorean, E. G., Infante, J., Moore, M., Seay, T., Tjulandin, S. A., Ma, W. W., Saleh, M. N., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304369 · Cited by 6,712
Burris, H. A., Moore, M. J., Andersen, J., Green, M. R., Rothenberg, M. L., Modiano, M. R., Cripps, M. C., Portenoy, R. K., Storniolo, A. M., Tarassoff, P., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2403 · Cited by 5,894
Scagliotti, G. V., Parikh, P., von Pawel, J., Biesma, B., Vansteenkiste, J., Manegold, C., Serwatowski, P., Gatzemeier, U., Digumarti, R., Zukin, M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0375 · Cited by 3,203
Broadening horizons: the role of ferroptosis in cancer
Chen, X., Kang, R., Kroemer, G., & Tang, D. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00462-0 · Cited by 2,897
Provenzano, P. P., Cuevas, C., Chang, A. E., Goel, V. K., Von Hoff, D. D., & Hingorani, S. R. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.01.007 · Cited by 2,195
Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance
Mashouri, L., Yousefi, H., Aref, A. R., Ahadi, A. M., Molaei, F., & Alahari, S. K. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0991-5 · Cited by 1,363
CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer
Zhang, H., Deng, T., Liu, R., Ning, T., Yang, H., Liu, D., Zhang, Q., Lin, D., Ge, S., Bai, M., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01168-8 · Cited by 1,016
Self-citationCancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells
Richards, K. E., Zeleniak, A. E., Fishel, M. L., Wu, J., Littlepage, L. E., & Hill, R. (2017) · Oncogene · doi:10.1038/onc.2016.353 · Cited by 735
miRNA interplay: mechanisms and consequences in cancer
Hill, M., & Tran, N. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.047662 · Cited by 674
Kou, M., Huang, L., Yang, J., Chiang, Z., Chen, S., Liu, J., Guo, L., Zhang, X., Zhou, X., Xu, X., et al. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-05034-x · Cited by 640
Self-citationPromotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations
Affo, S., Nair, A., Brundu, F., Ravichandra, A., Bhattacharjee, S., Matsuda, M., Chin, L., Filliol, A., Wen, W., Song, X., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.03.012 · Cited by 416
Gemcitabine resistance in pancreatic ductal adenocarcinoma
Binenbaum, Y., Na’ara, S., & Gil, Z. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.10.002 · Cited by 414
Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming
Li, Z., Sun, C., & Qin, Z. (2021) · Theranostics · doi:10.7150/thno.62378 · Cited by 390
Wen, S., Hou, Y., Fu, L., Xi, L., Yang, D., Zhao, M., Qin, Y., Sun, K., Teng, Y., & Liu, M. (2019) · Cancer Letters · doi:10.1016/j.canlet.2018.10.015 · Cited by 344
Li, Y.-Y., Tao, Y.-W., Gao, S., Li, P., Zheng, J.-M., Zhang, S.-E., Liang, J., & Zhang, Y. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.09.006 · Cited by 342
Ren, W., Hou, J., Yang, C., Wang, H., Wu, S., Wu, Y., Zhao, X., & Lu, C. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1027-0 · Cited by 341
Self-citationCancer-associated fibroblasts in tumor microenvironment–Accomplices in tumor malignancy
Liao, Z., Tan, Z. W., Zhu, P., & Tan, N. S. (2019) · Cellular Immunology · doi:10.1016/j.cellimm.2017.12.003 · Cited by 335
Exosomal miRNAs and miRNA dysregulation in cancer-associated fibroblasts
Yang, F., Ning, Z., Ma, L., Liu, W., Shao, C., Shu, Y., & Shen, H. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0718-4 · Cited by 329
Karasic, T. B., O’Hara, M. H., Loaiza-Bonilla, A., Reiss, K. A., Teitelbaum, U. R., Borazanci, E., De Jesus-Acosta, A., Redlinger, C., Burrell, J. A., Laheru, D. A., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.0684 · Cited by 293
Fibroblast Heterogeneity in the Pancreatic Tumor Microenvironment
Helms, E., Onate, M. K., & Sherman, M. H. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1353 · Cited by 283
FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cells
Ye, Z., Zhuo, Q., Hu, Q., Xu, X., liu, M., Zhang, Z., Xu, W., Liu, W., Fan, G., Qin, Y., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2020.101807 · Cited by 267
The Role of Cancer-Associated Fibroblasts in Cancer Invasion and Metastasis
Asif, P. J., Longobardi, C., Hahne, M., & Medema, J. P. (2021) · Cancers · doi:10.3390/cancers13184720 · Cited by 248
Chen, B., Sang, Y., Song, X., Zhang, D., Wang, L., Zhao, W., Liang, Y., Zhang, N., & Yang, Q. (2021) · Theranostics · doi:10.7150/thno.53412 · Cited by 225
Lu, Y., Chan, Y.-T., Tan, H.-Y., Zhang, C., Guo, W., Xu, Y., Sharma, R., Chen, Z.-S., Zheng, Y.-C., Wang, N., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02208-x · Cited by 211
Self-citationLeonetti, A., Wever, B., Mazzaschi, G., Assaraf, Y. G., Rolfo, C., Quaini, F., Tiseo, M., & Giovannetti, E. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.100644 · Cited by 200
Gemcitabine Resistance in Pancreatic Cancer: Picking the Key Players
Kim, M. P., & Gallick, G. E. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2247 · Cited by 177
Cancer‐associated fibroblasts that restrain cancer progression: Hypotheses and perspectives
Miyai, Y., Esaki, N., Takahashi, M., & Enomoto, A. (2020) · Cancer Science · doi:10.1111/cas.14346 · Cited by 177
Wu, H.-J., Hao, M., Yeo, S. K., & Guan, J.-L. (2020) · Oncogene · doi:10.1038/s41388-020-1162-2 · Cited by 165
Shi, L., Zhu, W., Huang, Y., Zhuo, L., Wang, S., Chen, S., Zhang, B., & Ke, B. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.989 · Cited by 165
Deoxycytidine release from pancreatic stellate cells promotes gemcitabine resistance
Dalin, S., Sullivan, M. R., Lau, A. N., Grauman-Boss, B., Mueller, H. S., Kreidl, E., Fenoglio, S., Luengo, A., Lees, J. A., Vander Heiden, M. G., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0960 · Cited by 156
Current and Emerging Therapies in Metastatic Pancreatic Cancer
Manji, G. A., Olive, K. P., Saenger, Y. M., & Oberstein, P. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2319 · Cited by 145
Thakur, A., Ke, X., Chen, Y., Motallebnejad, P., Zhang, K., Lian, Q., & Chen, H. J. (2021) · Protein & Cell · doi:10.1007/s13238-021-00863-6 · Cited by 141
Moore, A. M., & Donahue, T. R. (2019) · JAMA · doi:10.1001/jama.2019.14699 · Cited by 123
Jiang, X., Guo, S., Zhang, Y., Zhao, Y., Li, X., Jia, Y., Xu, Y. H., & Ma, B. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.109422 · Cited by 121
Self-citationSandiford, O. A., DONNELLY, R. J., El-Far, M. H., Burgmeyer, L. M., Sinha, G., Pamarthi, S. H., Sherman, L. S., Ferrer, A. I., DeVore, D. E., Patel, S. A., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2434 · Cited by 115
Hou, J. W., Jiang, C., Wen, X., Li, C., Xiong, S., Yue, T., Long, P., Shi, J., & Zhang, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.949863 · Cited by 101
Photodynamic therapy of pancreatic cancer: Where have we come from and where are we going?
Wang, Y., Wang, H., Zhou, L., Lü, J., Jiang, B., Liu, C., & Guo, J. (2020) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2020.101876 · Cited by 71
Self-citationFerroptosis: At the Crossroad of Gemcitabine Resistance and Tumorigenesis in Pancreatic Cancer
Yang, J., Xu, J., Zhang, B., Tan, Z., Meng, Q., Hua, J., Liu, J., Wang, W., Shi, S., Yu, X., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222010944 · Cited by 71
Richards, K. E., Xiao, W., Hill, R., & On Behalf Of The Usc Pancreas Research Team (2022) · Cancers · doi:10.3390/cancers14112812 · Cited by 70
Ham, I., Lee, D., & Hur, H. (2021) · Cancers · doi:10.3390/cancers13051172 · Cited by 64
Energy Sources for Exosome Communication in a Cancer Microenvironment
Thakur, A., Johnson, A. B., Jacobs, E., Zhang, K., Chen, J., Wei, Z., Lian, Q., & Chen, H. J. (2022) · Cancers · doi:10.3390/cancers14071698 · Cited by 61
Drug Resistance: The Role of Exosomal miRNA in the Microenvironment of Hematopoietic Tumors
Cariello, M., Squilla, A., Piacente, M., Venutolo, G., & Fasano, A. (2022) · Molecules · doi:10.3390/molecules28010116 · Cited by 31
LINC00893 inhibits the progression of prostate cancer through miR-3173-5p/SOCS3/JAK2/STAT3 pathway
Yu, C., Fan, Y., Zhang, Y., Liu, L., & Guo, G. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02637-4 · Cited by 28
The role of non-coding RNAs in ferroptosis regulation
Qi, R., Bai, Y., Wei, Y., Liu, N., & Shi, B. (2021) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2021.126911 · Cited by 25
Self-citationSun, Z., Tan, Z., Peng, C., & Yi, W. (2021) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-021-05160-5 · Cited by 18
Blomstrand, H., Gréen, H., Fredrikson, M. G., Gränsmark, E., Björnsson, B., & Elander, N. O. (2020) · BMC Cancer · doi:10.1186/s12885-020-07426-8 · Cited by 17
Cited by
Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies
Zhou, Q., Meng, Y., Li, D., Yao, L., Le, J., Liu, Y., Sun, Y., Zeng, F., Chen, X., & Deng, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01769-5 · Cited by 890
Iron Homeostasis and Ferroptosis in Human Diseases: Mechanisms and Therapeutic Prospects
Ru, Q., Li, Y., Chen, L., Wu, Y., Min, J., & Wang, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01969-z · Cited by 724
Lei, G., Zhuang, L., & Gan, B. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.03.011 · Cited by 586
Metadata
- Authors
- Qi, R., Bai, Y., Li, K., Liu, N., Xu, Y., Dal, E., Wang, Y., Lin, R., Wang, H., Liu, Z., Li, X., Wang, X., & Shi, B.
- Venue
- Drug Resistance Updates
- Publisher
- Elsevier BV
- Published
- 2023-05
- Volume
- 68
- Pages
- 100960
- ISSN
- 1368-7646 (ISSN-L)
- OpenAlex
- W4361222214
- Cited by
- 307
- References
- 51
- FWCI
- 22.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.